Cargando…
POOR PROGNOSTIC VALUE OF INFLAMMATORY MARKERS IN COVID-19 PNEUMONIA: A RETROSPECTIVE ANALYSIS
Autores principales: | GREWAL, S., MAYHUA, J., KNOX, H., MALAKKLA, N., BHARATI, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212328/ http://dx.doi.org/10.1016/j.chest.2021.12.131 |
Ejemplares similares
-
SYSTEMIC STEROIDS IN COVID-19 PNEUMONIA: A RETROSPECTIVE ANALYSIS
por: GREWAL, S., et al.
Publicado: (2022) -
ABO BLOOD TYPES AND INFLAMMATORY MARKERS IN COVID-19 PNEUMONIA
por: GO, R., et al.
Publicado: (2022) -
COST ANALYSIS FOR USE OF PROCALCITONIN AND INFLAMMATORY MARKERS IN COVID-19 VENTILATOR-ASSOCIATED PNEUMONIA
por: KIM, A., et al.
Publicado: (2022) -
INFLAMMATORY MARKERS AS PREDICTORS OF INTUBATION IN PATIENTS WITH COVID-19
por: KUMAR, SANT, et al.
Publicado: (2021) -
D-DIMER AS A SURROGATE MARKER OF DISEASE SEVERITY IN AFRICAN AMERICAN POPULATION WITH COVID-19 PNEUMONIA: A COMMUNITY HOSPITAL RETROSPECTIVE STUDY
por: OMORE, IBRAHIM, et al.
Publicado: (2021)